Registro:

Referencias:

• Targeted tuberculin testing and treatment of latent tuberculosis infection (2000) Am. J. Respir. Crit. Care Med., 161 (4), pp. S221-S247
• (2014) Global Tuberculosis Report, , Geneva
• Avena, S.A., Goicoechea, A.S., Rey, J., Dugoujon, J.M., Dejean, C.B., Carnese, F.R., Gene mixture in a population sample from Buenos Aires City (2006) Med. (B Aires), 66 (2), pp. 113-118
• Bashir, N., Kounsar, F., Mukhopadhyay, S., Hasnain, S.E., Mycobacterium tuberculosis conserved hypothetical protein rRv2626c modulates macrophage effector functions (2010) Immunology, 130 (1), pp. 34-45
• Black, G.F., Thiel, B.A., Ota, M.O., Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa (2009) Clin. Vaccine Immunol., 16 (8), pp. 1203-1212
• Cervantes-Villagrana, A.R., Hernandez-Pando, R., Biragyn, A., Prime-boost BCG vaccination with DNA vaccines based in beta-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model (2013) Vaccine, 31 (4), pp. 676-684
• Chegou, N.N., Hoek, K.G., Kriel, M., Warren, R.M., Victor, T.C., Walzl, G., Tuberculosis assays: past, present and future (2011) Expert Rev. Anti-Infect. Ther., 9 (4), pp. 457-469
• Chegou, N.N., Black, G.F., Loxton, A.G., Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting (2012) BMC Infect. Dis., 12, p. 10
• Corach, D., Lao, O., Bobillo, C., Inferring continental ancestry of Argentineans from autosomal, Y-chromosomal and mitochondrial DNA (2010) Ann. Hum. Genet., 74 (1), pp. 65-76
• Davila, J., McNamara, L.A., Yang, Z., Comparison of the predicted population coverage of tuberculosis vaccine candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a bioinformatics approach (2012) PLoS One, 7 (7), p. e40882
• Diel, R., Goletti, D., Ferrara, G., Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis (2011) Eur. Respir. J., 37 (1), pp. 88-99
• Dye, C., Scheele, S., Dolin, P., Pathania, V., Raviglione, M.C., Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project (1999) JAMA, 282 (7), pp. 677-686
• Ganguly, N., Siddiqui, I., Sharma, P., Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence (2008) Tuberculosis (Edinb.), 88 (6), pp. 510-517
• Goletti, D., Butera, O., Vanini, V., Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection (2010) Eur. Respir. J., 36 (1), pp. 135-142
• Hozumi, H., Tsujimura, K., Yamamura, Y., Immunogenicity of dormancy-related antigens in individuals infected with Mycobacterium tuberculosis in Japan (2013) Int. J. Tuberc. Lung Dis., 17 (6), pp. 818-824
• Leyten, E.M., Lin, M.Y., Franken, K.L., Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis (2006) Microbes Infect., 8 (8), pp. 2052-2060
• Lin, M.Y., Geluk, A., Smith, S.G., Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination (2007) Infect. Immun., 75 (7), pp. 3523-3530
• Mensah, G.I., Addo, K.K., Tetteh, J.A., Cytokine response to selected MTB antigens in Ghanaian TB patients, before and at 2weeks of anti-TB therapy is characterized by high expression of IFN-gamma and Granzyme B and inter-individual variation (2014) BMC Infect. Dis., 14, p. 495
• Pai, M., Denkinger, C.M., Kik, S.V., Gamma interferon release assays for detection of Mycobacterium tuberculosis infection (2014) Clin. Microbiol. Rev., 27 (1), pp. 3-20
• Perkins, N.J., Schisterman, E.F., The inconsistency of optimal cutpoints obtained using two criteria based on the receiver operating characteristic curve (2006) Am. J. Epidemiol., 163 (7), pp. 670-675
• Reither, K., Katsoulis, L., Beattie, T., Safety and immunogenicity of H1/IC31(R), an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts greater than 350cells/mm 3 : a phase II, multi-centre, double-blind, randomized, placebo-controlled trial (2014) PloS One, 9 (12), p. e114602
• Riano, F., Arroyo, L., Paris, S., T cell responses to DosR and Rpf proteins in actively and latently infected individuals from Colombia (2012) Tuberculosis, 92 (2), pp. 148-159
• Rosenkrands, I., Slayden, R.A., Crawford, J., Aagaard, C., Barry, C.E., Andersen, P., Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins (2002) J. Bacteriol., 184 (13), pp. 3485-3491
• Sauzullo, I., Vullo, V., Mastroianni, C.M., Detecting latent tuberculosis in compromised patients (2015) Curr Opin Infect Dis, 28 (3), pp. 275-282
• Schuck, S.D., Mueller, H., Kunitz, F., Identification of T-cell antigens specific for latent Mycobacterium tuberculosis infection (2009) PLoS One, 4 (5), p. e5590
• Sester, M., Sotgiu, G., Lange, C., Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis (2011) Eur. Respir. J., 37 (1), pp. 100-111
• Shingadia, D., Novelli, V., The tuberculin skin test: a hundred, not out? (2008) Arch. Dis. Child., 93 (3), pp. 189-190
• van Dissel, J.T., Soonawala, D., Joosten, S.A., Ag85B-ESAT-6 adjuvanted with IC31(R) promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection (2011) Vaccine, 29 (11), pp. 2100-2109
• Vukmanovic-Stejic, M., Reed, J.R., Lacy, K.E., Rustin, M.H., Akbar, A.N., Mantoux test as a model for a secondary immune response in humans (2006) Immunol. Lett., 107 (2), pp. 93-101
• Youden, W.J., Index for rating diagnostic tests (1950) Cancer, 3 (1), pp. 32-35
• Zerbini, E.V., (2013) Programa Nacional de Control de la Tuberculosis: Normas Técnicas, , Instituto Nacional de Enfermedades Respiratorias Dr. Emilio Coni, Santa Fe, Argentina

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------